Dicamba controversy: EPA’s decision on herbicide’s future expected by end of September

dicamba soybeans
A field of dicamba-resistant soybeans

Throughout this year, EPA has been monitoring reports during the application season and it’s expected the agency will announce its decision for the future of …. dicamba products by the end of September.

For review… in 2016, EPA registered the new dicamba formulations for over-the-top use (Engenia, FeXapan and Xtendimax). When the new products were registered, the EPA set the regulations to automatically expire in two years, which would allow the EPA to review and change the registration if necessary.

According to Monsanto, the company has received 381 calls and has visited 299 of those farms with complaints as of July 12. As of July 15, Kevin Bradley at the University of Missouri assembled 605 dicamba-related injury investigations from state departments of agriculture.

The Illinois Fertilizer and Chemical Association received survey responses from more than 110 professional applicators about their experience with dicamba in 2018.  As of mid-August, the Illinois Department of Agriculture has received 319 misuse complaints attributed to dicamba symptoms (the total number of pesticide misuse complaints so far in 2018 totals 500, which is a historic high.) Those survey responses (in addition to their ongoing conversations with stakeholders) led to the IFCA sending four recommendations to the EPA for their consideration in weighing their decision for dicamba’s future.

So for now, we wait.

Read full, original article: Waiting For Dicamba’s Second Shoe to Drop

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
Screenshot-2026-07-10-at-2.02.54-PM
Viewpoint: In abortion-restricting Florida, misinformation abounds when Republican congresswoman faces an ectopic pregnancy
ChatGPT-Image-Jul-7-2026-01_57_55-PM
Viewpoint: Europe’s rejection of air conditioning is the poster child for misunderstanding how to mitigate the impact of climate change
Screenshot-2026-07-10-at-3.10.50-PM
Snake-oil cures throughout history
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
Screenshot-2026-07-10-at-12.55.21-PM
Cancer health facts are particularly susceptible to online misinformation
Screen-Shot-at-PM-pe-vra-kipgaprbdo-vd-ms-jpule-n-jqqaxf-l-e
Viewpoint: Will new breeding techniques help make European agriculture more competitive?
Screenshot-2026-07-10-at-3.25.10-PM
Using AI for health questions? Here are 4 tips for the most accurate answers.
Viewpoint: Consensus as truth? How ‘misinformation police’ control policy narratives
Which among war, weather and cyber attacks is the biggest world threat? None of the above. It’s misinformation, and here’s why.
ChatGPT-Image-Jul-1-2026-03_33_49-PM
‘Alternative’ cancer treatments that could kill you
Gemini_Generated_Image_gabo48gabo48gabo
Viewpoint: A plastic surgeon on why banning gender-transition surgery without further research is wrong and harmful
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.